ProCE Banner Activity

Incorporating TROP-2–Targeted Therapies Into the Breast Cancer Landscape

Slideset

Download these slides from a live symposium at ASCO 2023 to learn more about TROP-2 targeted therapies for patients with breast cancer.

Released: June 02, 2023

Share

Faculty

Aditya Bardia

Aditya Bardia, MD, MPH

Director, Breast Cancer Research
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.

AstraZeneca

Daiichi Sankyo

Gilead Sciences, Inc.